In 2021, the 30.7 million beneficiaries accounted for over $2 billion in payments for the 101 generic drugs. Under the ...

The battle against drug resistance in lung cancer therapy remains a critical issue in oncology, with resistance mechanisms ...

Researchers at Indiana University and Wuhan University in China have unveiled a groundbreaking chemical process that could streamline the development of pharmaceutical compounds, chemical building ...

FRANKFURT, March 9 (Reuters) - Europe should reduce its dependence on a small number of countries for vital drug supplies such as antibiotics and anaesthetics to boost the bloc's preparedness for ...

Fujian Key Laboratory of Drug Target Discovery and Structural and Functional Research, School of Pharmacy, Fujian Medical University, Fuzhou 350122, China Fujian Key Laboratory of Drug Target ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

In the current study, the researchers used what is known as fragment-based drug design instead. The method involves first identifying a very small molecule that can bind to the target protein.

Feb 25 (Reuters) - Nearly 87,000 Americans died from drug overdose in the United States in the 12-month period ending September 2024, a decline of about 24% from the previous year, according to ...

There's an arms race in medicine -- scientists design drugs to treat lethal bacterial infections, but bacteria can evolve defenses to those drugs, sending the researchers back to square one.

Fragment-based drug design (FBDD) has emerged as a powerful strategy in drug discovery, offering a complementary approach to traditional high-throughput screening (HTS)-based drug discovery. Over ...

Generic drugs have saved billions of dollars and benefited countless lives by making existing medicines more affordable. But a new study finds these drug copies may not all be created equal. Despite ...